Evidence map›Paper›PMID 33403511›Full record

ArticleVirchows Archiv : an international journal of pathology2021

Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer.

Behnoush Abedi-Ardekani, Dariush Nasrollahzadeh, Lars Egevad, Rosamonde E Banks, Naveen Vasudev, Ivana Holcatova, Ctibor Povysil, Lenka Foretova, Vladimir Janout, Dana Mates and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 8 countries.

Behnoush Abedi-ArdekaniInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France. abedib@iarc.fr.ORCID https://orcid.org/0000-0002-0980-0587
Dariush NasrollahzadehInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France.
Lars EgevadDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Rosamonde E BanksLeeds Institute of Medical Research @ St James's, University of Leeds, Leeds, UK.
Naveen VasudevLeeds Institute of Medical Research @ St James's, University of Leeds, Leeds, UK.
Ivana HolcatovaFirst Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Ctibor PovysilInstitute of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Lenka ForetovaDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Vladimir JanoutCentre of Science and Research, Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
Dana MatesNational Institute of Public Health, Bucharest, Romania.
Viorel JingaCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Amelia PetrescuPathology Department, Professor Dr. Th. Burghele Clinical Hospital, Bucharest, Romania.
Sasa MilosavljevicInternational Organization for Cancer Prevention and Research, Belgrade, Serbia.
Miodrag OgnjanovicInternational Organization for Cancer Prevention and Research, Belgrade, Serbia.
Simona OgnjanovicInternational Organization for Cancer Prevention and Research, Belgrade, Serbia.
Juris ViksnaInstitute of Mathematics and Computer Science, University of Latvia, Riga, Latvia.
Anne Y WarrenCambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
Mark LathropMcGill University and Génome Québec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Yasser RiazalhosseiniMcGill University and Génome Québec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Christine CarreiraInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France.
Estelle ChanudetInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France.
James McKayInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France.
Paul BrennanInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France.
Ghislaine ScéloInternational Agency for Research on Cancer, World Health Organization, 150 Cours Albert Thomas, 69372, Lyon Cedex 8, France.
Centre international de recherche sur le cancer · FRCharles University · CZMcGill University and Génome Québec Innovation Centre · CAUniversity of Leeds · GBCambridge University Hospitals NHS Foundation Trust · GBCarol Davila University of Medicine and Pharmacy · ROClinical Emergency Hospital Bucharest · ROKarolinska Institutet · SEMasaryk Memorial Cancer Institute · CZPalacký University Olomouc · CZUniversity of Latvia · LV

Funding

World Health Organization 001
6 · The paper itself

Abstract

There are unexplained geographical variations in the incidence of kidney cancer with the high rates reported in Baltic countries, as well as eastern and central Europe. Having access to a large and well-annotated collection of "tumor/non-tumor" pairs of kidney cancer patients from the Czech Republic, Romania, Serbia, UK, and Russia, we aimed to analyze the morphology of non-neoplastic renal tissue in nephrectomy specimens. By applying digital pathology, we performed a microscopic examination of 1012 frozen non-neoplastic kidney tissues from patients with renal cell carcinoma. Four components of renal parenchyma were evaluated and scored for the intensity of interstitial inflammation and fibrosis, tubular atrophy, glomerulosclerosis, and arterial wall thickening, globally called chronic renal parenchymal changes. Moderate or severe changes were observed in 54 (5.3%) of patients with predominance of occurrence in Romania (OR = 2.67, CI 1.07-6.67) and Serbia (OR = 4.37, CI 1.20-15.96) in reference to those from Russia. Further adjustment for comorbidities, tumor characteristics, and stage did not change risk estimates. In multinomial regression model, relative probability of non-glomerular changes was 5.22 times higher for Romania and Serbia compared to Russia. Our findings show that the frequency of chronic renal parenchymal changes, with the predominance of chronic interstitial nephritis pattern, in kidney cancer patients varies by country, significantly more frequent in countries located in central and southeastern Europe where the incidence of kidney cancer has been reported to be moderate to high. The observed association between these pathological features and living in certain geographic areas requires a larger population-based study to confirm this association on a large scale.

Indexed as

AdultAgedCarcinoma, Renal CellEuropeFemaleFibrosisGlomerular Filtration RateHumansKidneyKidney NeoplasmsMaleMiddle AgedNephrectomyRussiaFrozen kidney tissueKidney cancerMicroscopyNon-neoplastic kidneyRenal cell carcinomaRenal parenchyma

Identifiers

PMID33403511
PMCPMC8203524
OpenAlexW3120052833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.